WALDENCAST PLC-A (WALD)

JE00BPG99318 - Common Stock

3.07  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to WALD. WALD was compared to 37 industry peers in the Personal Care Products industry. WALD may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, WALD is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

WALD had negative earnings in the past year.

1.2 Ratios

The Return On Assets of WALD (-8.88%) is worse than 72.22% of its industry peers.
The Return On Equity of WALD (-14.55%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -8.88%
ROE -14.55%
ROIC N/A
ROA(3y)-7.83%
ROA(5y)N/A
ROE(3y)-12.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

WALD's Gross Margin of 64.90% is in line compared to the rest of the industry. WALD outperforms 55.56% of its industry peers.
The Profit Margin and Operating Margin are not available for WALD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

WALD does not have a ROIC to compare to the WACC, probably because it is not profitable.
WALD has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, WALD has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.21, we must say that WALD is in the distress zone and has some risk of bankruptcy.
WALD has a worse Altman-Z score (0.21) than 75.00% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that WALD is not too dependend on debt financing.
WALD has a Debt to Equity ratio (0.23) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACCN/A
WACC9.01%

2.3 Liquidity

WALD has a Current Ratio of 1.47. This is a normal value and indicates that WALD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of WALD (1.47) is worse than 61.11% of its industry peers.
WALD has a Quick Ratio of 1.47. This is a bad value and indicates that WALD is not financially healthy enough and could expect problems in meeting its short term obligations.
WALD has a worse Quick ratio (0.78) than 63.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.78

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.82% over the past year.
The Revenue has grown by 31.30% in the past year. This is a very strong growth!
EPS 1Y (TTM)26.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.23%
Revenue 1Y (TTM)31.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-42.11%

3.2 Future

WALD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.71% yearly.
The Revenue is expected to grow by 17.90% on average over the next years. This is quite good.
EPS Next Y-278.57%
EPS Next 2Y-65.23%
EPS Next 3Y-54.33%
EPS Next 5Y41.71%
Revenue Next Year-2.48%
Revenue Next 2Y7.97%
Revenue Next 3Y11.2%
Revenue Next 5Y17.9%

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

WALD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year WALD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

WALD's earnings are expected to decrease with -54.33% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-65.23%
EPS Next 3Y-54.33%

0

5. Dividend

5.1 Amount

WALD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WALDENCAST PLC-A

NASDAQ:WALD (1/15/2025, 10:25:50 AM)

3.07

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-20 2024-11-20/amc
Earnings (Next)01-21 2025-01-21/amc
Inst Owners22.08%
Inst Owner Change0%
Ins Owners2.71%
Ins Owner ChangeN/A
Market Cap377.15M
Analysts80
Price Target5.88 (91.53%)
Short Float %0.6%
Short Ratio2.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.99%
PT rev (3m)0.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.35%
EPS NY rev (3m)-75.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.73
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.78
BVpS5.04
TBVpS-2.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.88%
ROE -14.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.9%
FCFM N/A
ROA(3y)-7.83%
ROA(5y)N/A
ROE(3y)-12.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 0.78
Altman-Z 0.21
F-ScoreN/A
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.23%
EPS Next Y-278.57%
EPS Next 2Y-65.23%
EPS Next 3Y-54.33%
EPS Next 5Y41.71%
Revenue 1Y (TTM)31.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-42.11%
Revenue Next Year-2.48%
Revenue Next 2Y7.97%
Revenue Next 3Y11.2%
Revenue Next 5Y17.9%
EBIT growth 1Y-10.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.14%
EBIT Next 3Y23.79%
EBIT Next 5Y37.21%
FCF growth 1Y63.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.98%
OCF growth 3YN/A
OCF growth 5YN/A